Showing results (101-110 of 114) with videos related to
Sort By:
Pageof 12
RMD Open|October 29, 2015
The impact of patient heterogeneity and socioeconomic factors on abatacept retention in rheumatoid arthritis across nine European countriesA Finckh, D Neto, F Iannone, et al.Reumatismo|April 2, 2019
Occult HBV infection may negatively impact on drug survival in patients with rheumatoid arthritis on treatment with a first biologic drug. An appraisal from the Biologic Apulian Registry (BIOPURE)G Carlino, M Fornaro, L Santo, et al.Nature Neuroscience|December 22, 2025
Genetic mapping identifies Homer1 as a developmental modifier of attentionZachary Gershon, Alessandra Bonito-Oliva, Matt Kanke, et al.Reumatismo|March 8, 2021
Pulmonary arterial hypertension: guidelines and unmet clinical needsD Giuggioli, C Bruni, F Cacciapaglia, et al.Infection|May 28, 2009
Hyperbilirubinemia during atazanavir treatment in 2,404 patients in the Italian atazanavir expanded access program and MASTER CohortsC Torti, G Lapadula, A Antinori, et al.Biorxiv : the Preprint Server for Biology|March 30, 2023
Genetic mapping identifies Homer1 as a developmental modifier of attentionZachary Gershon, Alessandra Bonito-Oliva, Matt Kanke, et al.Ebiomedicine|August 26, 2016
Rheumatoid Arthritis Patients after Initiation of a New Biologic Agent: Trajectories of Disease Activity in a Large Multinational Cohort StudyD S Courvoisier, D Alpizar-Rodriguez, J E Gottenberg, et al.British Journal of Pharmacology|December 10, 2022
Non-neuronal TRPA1 encodes mechanical allodynia associated with neurogenic inflammation and partial nerve injury in ratsFrancesco De Logu, Gaetano De Siena, Lorenzo Landini, et al.Epilepsy & Behavior : E&B|February 13, 2021
Appropriate use of generic and branded antiseizure medications in epilepsy: Updated recommendations from the Italian League Against Epilepsy (LICE)Roberta Roberti, Alessandro Casarella, Alfonso Iudice, et al.Infection|February 8, 2024
Drugs for treating infections caused by non-tubercular mycobacteria: a narrative review from the study group on mycobacteria of the Italian Society of Infectious Diseases and Tropical MedicineA Calcagno, N Coppola, L Sarmati, et al.Pageof 12